Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients-Reference-Cited by-同舟云学术

Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients

Published:2018-08-29 Issue:8 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Abdul Wahid S Fadilah¹²,Ismail Nor Azimah¹,Wan Jamaludin Wan Fariza¹,Muhamad Nor Asiah³,Abdul Hamid Muhammad Khairul Azaham¹,Harunarashid Hanafiah⁴,Lai Nai Ming⁵

Affiliation:

1. Universiti Kebangsaan Malaysia Medical Centre; Cell Therapy Center; Jalan Yaacob Latif Kuala Lumpur Malaysia 56000

2. Universiti Kebangsaan Malaysia Medical Centre; Clinical Haematology & Stem Cell Transplantation Services, Department of Medicine; Kuala Lumpur Malaysia

3. Ministry of Health; Institute for Public Health; Kuala Lumpur Federal Teritory Malaysia 50590

4. Universiti Kebangsaan Malaysia Medical Centre; Unit of Vascular Surgery, Department of Surgery; Jalan Yaacob Latif Kuala Lumpur Kuala Lumpur Malaysia 56000

5. Taylor's University; School of Medicine; Subang Jaya Malaysia

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010747.pub2/epdf/full

Reference202 articles.

1. Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia;Gu;Chinese Medical Journal,2008

2. Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans;Huang;Thrombosis and Haemostasis,2007

3. No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia;Klepanec;Cell Transplantation,2012

4. Autologous bone marrow cells transplantation in patients with advanced critical limb ischemia: no difference in intra-arterial and intramuscular application;Madaric;Journal of the American College of Cardiology,2011

5. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia;Losordo;Circulation. Cardiovascular Interventions,2012

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arterial Leg Ulcers in the Octogenarian;Clinics in Geriatric Medicine;2024-08

2. The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics;MedComm;2024-07-28

3. Atorvastatin Treatment Significantly Increased the Concentration of Bone Marrow-Derived Mononuclear Cells and Transcutaneous Oxygen Pressure and Lowered the Pain Scale after Bone Marrow Cells Treatment in Patients with “No-Option” Critical Limb Ischaemia;Biomedicines;2024-04-22

4. Fetal progenitor cells for treatment of chronic limb ischemia;American Journal of Stem Cells;2024

5. HTATIP2 regulates arteriogenic activity in monocytes from patients with limb ischemia;JCI Insight;2023-12-22